A cluster of coregulated genes determines TGF-β - Induced regulatory T-cell (Treg) dysfunction in NOD mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 21, 2011, Pages 8737-8742

  D'Alise, Anna Morena ^a   Ergun, Ayla ^a   Hill, Jonathan A ^a,b   Mathis, Diane ^a   Benoist, Christophe ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Tempero Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CARRIER PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROTEIN LRRC32; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; GENE CLUSTER; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN;

ANIMALS; CLUSTER ANALYSIS; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; MICE; MICE, INBRED NOD; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

MUS;

EID: 79957764739     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1105364108     Document Type: Article

References (50)

1. Salomon B, et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440.
2. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM (2004) CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 199:1467-1477. (Pubitemid 38780402)
3. Tang Q, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199:1455-1465.
4. Herman AE, Freeman GJ, Mathis D, Benoist C (2004) CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 199:1479-1489. (Pubitemid 38780403)
5. Chen Z, Herman AE, Matos M, Mathis D, Benoist C (2005) Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 202:1387-1397. (Pubitemid 41668741)
6. Mellanby RJ, Thomas D, Phillips JM, Cooke A (2007) Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 121:15-28. (Pubitemid 46537670)
7. Feuerer M, et al. (2007) Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc Natl Acad Sci USA 104:18181-18186. (Pubitemid 350210841)
8. Tang Q, et al. (2008) Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28:687-697.
9. You S, et al. (2005) Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54:1415-1422. (Pubitemid 40586672)
10. Gregori S, Giarratana N, Smiroldo S, Adorini L (2003) Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 171:4040-4047. (Pubitemid 37238678)
11. Thomas DC, Mellanby RJ, Phillips JM, Cooke A (2007) An early age-related increase in the frequency of CD4+ Foxp3+ cells in BDC2.5NOD mice. Immunology 121:565-576. (Pubitemid 47030094)
12. D'Alise AM, et al. (2008) The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci USA 105:19857-19862.
13. Schneider A, et al. (2008) The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J Immunol 181:7350-7355.
14. Apostolou I, von Boehmer H (2004) In vivo instruction of suppressor commitment in naive T cells. J Exp Med 199:1401-1408.
15. Kretschmer K, et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219-1227. (Pubitemid 43045633)
16. Curotto de Lafaille MA, et al. (2008) Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29:114-126.
17. Feuerer M, et al. (2010) Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc Natl Acad Sci USA 107:5919-5924.
18. Finney CA, Taylor MD, Wilson MS, Maizels RM (2007) Expansion and activation of CD4(+)CD25(+) regulatory T cells in Heligmosomoides polygyrus infection. Eur J Immunol 37:1874-1886. (Pubitemid 47065126)
19. Coombes JL, et al. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204:1757-1764. (Pubitemid 47236314)
20. Mucida D, et al. (2005) Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 115:1923-1933. (Pubitemid 40979732)
21. Sun CM, et al. (2007) Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204:1775-1785.
22. Nishio J, Feuerer M, Wong J, Mathis D, Benoist C (2010) Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints. J Exp Med 207:1879-1889.
23. Atarashi K, et al. (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-341.
24. ChenW, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875-1886.
25. Floess S, et al. (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5:e38.
26. Hill JA, et al. (2007) Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27:786-800. (Pubitemid 350110546)
27. Aricha R, Feferman T, Fuchs S, Souroujon MC (2008) Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis. J Immunol 180:2132-2139.
28. Davidson TS, DiPaolo RJ, Andersson J, Shevach EM (2007) Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 178:4022-4026. (Pubitemid 46492349)
29. Huter EN, et al. (2008) TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur J Immunol 38:1814-1821.
30. Wang R, et al. (2009) Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 106:13439-13444.
31. Deaglio S, et al. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257-1265. (Pubitemid 46919862)
32. Wing K, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322:271-275.
33. Heng TS, Painter MW; Immunological Genome Project Consortium (2008) The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol 9:1091-1094.
34. Tran DQ, et al. (2009) GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 106:13445-13450.
35. Stockis J, Colau D, Coulie PG, Lucas S (2009) Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 39:3315-3322.
36. Thornton AM, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184:3433-3441.
37. Yamanouchi J, et al. (2007) Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 39:329-337. (Pubitemid 46328484)
38. Lyons PA, et al. (2000) Congenic mapping of the type 1 diabetes locus, Idd3, to a 780- kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res 10:446-453. (Pubitemid 30259075)
39. Hunter K, et al. (2007) Interactions between Idd5.1/Ctla4 and other type 1 diabetes genes. J Immunol 179:8341-8349.
40. Lamhamedi-Cherradi SE, et al. (2001) Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice. Diabetes 50:2874-2878.
41. Ueda H, et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511. (Pubitemid 36648570)
42. Vijayakrishnan L, et al. (2004) An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20:563-575. (Pubitemid 38638126)
43. Lundholm M, et al. (2006) Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1. Diabetes 55:538-544. (Pubitemid 43343287)
44. Zheng Y, et al. (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463:808-812.
45. Vaarala O, Atkinson MA, Neu J (2008) The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555-2562.
46. Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C (2005) Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci USA 102:17729-17733. (Pubitemid 41803565)
47. Jiang W, Anderson MS, Bronson R, Mathis D, Benoist C (2005) Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 202:805-815. (Pubitemid 41345969)
48. Mathis D, Benoist C (2004) Back to central tolerance. Immunity 20:509-516. (Pubitemid 38638121)
49. Badami E, (2010) Defective FoxP3+ Treg cell differentiation in the gut of type 1 diabetic patients. Nat Precedings. Available at http://hdl.handle.net/ 10101/npre.2010.4417.1. Accessed February 21, 2011.
50. Iwai LK, Benoist C, Mathis D, White FM (2010) Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. J Proteome Res 9:3135-3145.